October 1, 2021 - Equitable Life of Canada® announced today that it has partnered with Personalized Prescribing Inc. to provide easier access to pharmacogenomic testing for plan members with mental health conditions.
Pharmacogenomics is the study of how an individual’s genes influence their response to medications. Pharmacogenomic testing can help determine how compatible a patient’s body may be to a particular drug, and helps their physician prescribe the most appropriate medication. The goal is to ensure the right drug is prescribed to deliver the most positive outcome with the fewest side effects.
“Patients suffering from mental health conditions often need to try several medications before they find one that works for them,” says Maureen Long, Group Claims, Administration and Disability Vice President at Equitable Life. “This is frustrating and can result in negative side-effects. Pharmacogenomics can help plan members avoid this treatment trial and error.”
Through the partnership with Personalized Prescribing Inc., any Equitable Life plan member diagnosed with a mental health condition can purchase a pharmacogenomic test for a discounted price of $399 plus HST – a 20% savings.
Equitable Life is also introducing the option for plan sponsors to add coverage of pharmacogenomic tests provided by Personalized Prescribing Inc. for their plan members suffering with mental health conditions.
“We are proud to partner with Equitable Life to make this important service more accessible to Equitable Life plan members suffering from mental health conditions” says Mark Faiz, President and CEO, Personalized Prescribing Inc.
To learn more about pharmacogenomic testing through Equitable Life and Personalized Prescribing Inc., please visit www.personalizedprescribing.com/equitablelife. To request coverage for your plan members, please contact your advisor.
® denotes a registered trademark of The Equitable Life Insurance Company of Canada.
